Antipsychotic Drugs Market Size, Trends, Analysis, and Outlook By Class Type, First Generation, Second Generation, Third generation), By Application (Schizophrenia, Bipolar disorders, Dementia, Unipolar Depression, Others), by Region, Country, Segment, and Companies, 2024-2030
The global Antipsychotic Drugs market size is poised to register 7.88% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Antipsychotic Drugs market across By Class Type, First Generation, Second Generation, Third generation), By Application (Schizophrenia, Bipolar disorders, Dementia, Unipolar Depression, Others).
The Antipsychotic Drugs Market is experiencing significant growth and therapeutic innovation in 2024 and beyond, driven by the rising prevalence of psychiatric disorders, advances in neuroscience, and the development of novel pharmacological agents targeting psychosis and related symptoms. Antipsychotic drugs represent a cornerstone of treatment for schizophrenia, bipolar disorder, and other psychotic disorders, exerting their therapeutic effects by modulating neurotransmitter pathways in the brain. Key trends include the development of next-generation antipsychotics, long-acting injectable formulations, and adjunctive therapies targeting cognitive impairment and negative symptoms associated with schizophrenia. Additionally, there is a growing emphasis on personalized treatment approaches, genetic biomarkers, and digital therapeutics to tailor antipsychotic therapy based on individual patient characteristics, treatment response, and side effect profiles. Moreover, collaborative research consortia, patient registries, and real-world evidence studies are essential for advancing evidence-based practice guidelines, optimizing treatment algorithms, and improving outcomes for patients with severe and persistent mental illness worldwide.
Antipsychotic Drugs Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Antipsychotic Drugs market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Antipsychotic Drugs survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Antipsychotic Drugs industry.
Key market trends defining the global Antipsychotic Drugs demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Antipsychotic Drugs Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Antipsychotic Drugs industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Antipsychotic Drugs companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Antipsychotic Drugs industry
Leading Antipsychotic Drugs companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Antipsychotic Drugs companies.
Antipsychotic Drugs Market Study- Strategic Analysis Review
The Antipsychotic Drugs market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
The Antipsychotic Drugs industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Antipsychotic Drugs Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Antipsychotic Drugs Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Antipsychotic Drugs market segments. Similarly, Strong end-user demand is encouraging Canadian Antipsychotic Drugs companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Antipsychotic Drugs market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Antipsychotic Drugs Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Antipsychotic Drugs industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Antipsychotic Drugs market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Antipsychotic Drugs Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Antipsychotic Drugs in Asia Pacific. In particular, China, India, and South East Asian Antipsychotic Drugs markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Antipsychotic Drugs Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Antipsychotic Drugs Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Antipsychotic Drugs market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Antipsychotic Drugs.
Antipsychotic Drugs Market Company Profiles
The global Antipsychotic Drugs market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are AbbVie Inc, Acadia Pharmaceuticals Inc, Alkermes, AstraZeneca plc, Eli Lily and Company, GlaxoSmithKline plc, H. Lundbeck A/S, Intra-Cellular Therapies Inc, Johnson & Johnson, Otsuka Pharmaceutical Co Ltd, Pfizer Inc, Sumitomo Pharma Co. Ltd, Teva Pharmaceutical Industries Ltd
Recent Antipsychotic Drugs Market Developments
The global Antipsychotic Drugs market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Antipsychotic Drugs Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
By Class Type
First Generation
-Haldo
-Navane
-Others
Second Generation
-Invega
-Latuda
-Seroquel
-Risperdal
-Zyprexa
-Geodon
-Others
Third generation
-Abilify
By Application
Schizophrenia
Bipolar disorders
Dementia
Unipolar Depression
Others
Geographical Segmentation:
AbbVie Inc
Acadia Pharmaceuticals Inc
Alkermes
AstraZeneca plc
Eli Lily and Company
GlaxoSmithKline plc
H. Lundbeck A/S
Intra-Cellular Therapies Inc
Johnson & Johnson
Otsuka Pharmaceutical Co Ltd
Pfizer Inc
Sumitomo Pharma Co. Ltd
Teva Pharmaceutical Industries Ltd
Formats Available: Excel, PDF, and PPT
The Antipsychotic Drugs Market is experiencing significant growth and therapeutic innovation in 2024 and beyond, driven by the rising prevalence of psychiatric disorders, advances in neuroscience, and the development of novel pharmacological agents targeting psychosis and related symptoms. Antipsychotic drugs represent a cornerstone of treatment for schizophrenia, bipolar disorder, and other psychotic disorders, exerting their therapeutic effects by modulating neurotransmitter pathways in the brain. Key trends include the development of next-generation antipsychotics, long-acting injectable formulations, and adjunctive therapies targeting cognitive impairment and negative symptoms associated with schizophrenia. Additionally, there is a growing emphasis on personalized treatment approaches, genetic biomarkers, and digital therapeutics to tailor antipsychotic therapy based on individual patient characteristics, treatment response, and side effect profiles. Moreover, collaborative research consortia, patient registries, and real-world evidence studies are essential for advancing evidence-based practice guidelines, optimizing treatment algorithms, and improving outcomes for patients with severe and persistent mental illness worldwide.
Antipsychotic Drugs Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Antipsychotic Drugs market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Antipsychotic Drugs survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Antipsychotic Drugs industry.
Key market trends defining the global Antipsychotic Drugs demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Antipsychotic Drugs Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Antipsychotic Drugs industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Antipsychotic Drugs companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Antipsychotic Drugs industry
Leading Antipsychotic Drugs companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Antipsychotic Drugs companies.
Antipsychotic Drugs Market Study- Strategic Analysis Review
The Antipsychotic Drugs market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
- Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
- Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
- Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
- Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.
The Antipsychotic Drugs industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Antipsychotic Drugs Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Antipsychotic Drugs Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Antipsychotic Drugs market segments. Similarly, Strong end-user demand is encouraging Canadian Antipsychotic Drugs companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Antipsychotic Drugs market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Antipsychotic Drugs Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Antipsychotic Drugs industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Antipsychotic Drugs market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Antipsychotic Drugs Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Antipsychotic Drugs in Asia Pacific. In particular, China, India, and South East Asian Antipsychotic Drugs markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Antipsychotic Drugs Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Antipsychotic Drugs Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Antipsychotic Drugs market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Antipsychotic Drugs.
Antipsychotic Drugs Market Company Profiles
The global Antipsychotic Drugs market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are AbbVie Inc, Acadia Pharmaceuticals Inc, Alkermes, AstraZeneca plc, Eli Lily and Company, GlaxoSmithKline plc, H. Lundbeck A/S, Intra-Cellular Therapies Inc, Johnson & Johnson, Otsuka Pharmaceutical Co Ltd, Pfizer Inc, Sumitomo Pharma Co. Ltd, Teva Pharmaceutical Industries Ltd
Recent Antipsychotic Drugs Market Developments
The global Antipsychotic Drugs market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Antipsychotic Drugs Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
- Pricing Analysis
- Value Chain Analysis
- SWOT Profile
- Market Dynamics- Trends, Drivers, Challenges
- Porter’s Five Forces Analysis
- Macroeconomic Impact Analysis
- Case Scenarios- Low, Base, High
By Class Type
First Generation
-Haldo
-Navane
-Others
Second Generation
-Invega
-Latuda
-Seroquel
-Risperdal
-Zyprexa
-Geodon
-Others
Third generation
-Abilify
By Application
Schizophrenia
Bipolar disorders
Dementia
Unipolar Depression
Others
Geographical Segmentation:
- North America (3 markets)
- Europe (6 markets)
- Asia Pacific (6 markets)
- Latin America (3 markets)
- Middle East Africa (5 markets)
AbbVie Inc
Acadia Pharmaceuticals Inc
Alkermes
AstraZeneca plc
Eli Lily and Company
GlaxoSmithKline plc
H. Lundbeck A/S
Intra-Cellular Therapies Inc
Johnson & Johnson
Otsuka Pharmaceutical Co Ltd
Pfizer Inc
Sumitomo Pharma Co. Ltd
Teva Pharmaceutical Industries Ltd
Formats Available: Excel, PDF, and PPT
1. EXECUTIVE SUMMARY
1.1 Antipsychotic Drugs Market Overview and Key Findings, 2024
1.2 Antipsychotic Drugs Market Size and Growth Outlook, 2021- 2030
1.3 Antipsychotic Drugs Market Growth Opportunities to 2030
1.4 Key Antipsychotic Drugs Market Trends and Challenges
1.4.1 Antipsychotic Drugs Market Drivers and Trends
1.4.2 Antipsychotic Drugs Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Antipsychotic Drugs Companies
2. ANTIPSYCHOTIC DRUGS MARKET SIZE OUTLOOK TO 2030
2.1 Antipsychotic Drugs Market Size Outlook, USD Million, 2021- 2030
2.2 Antipsychotic Drugs Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. ANTIPSYCHOTIC DRUGS MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. ANTIPSYCHOTIC DRUGS MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Class Type
First Generation
-Haldo
-Navane
-Others
Second Generation
-Invega
-Latuda
-Seroquel
-Risperdal
-Zyprexa
-Geodon
-Others
Third generation
-Abilify
By Application
Schizophrenia
Bipolar disorders
Dementia
Unipolar Depression
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Antipsychotic Drugs Market, 2025
5.2 Asia Pacific Antipsychotic Drugs Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Antipsychotic Drugs Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Antipsychotic Drugs Market, 2025
5.5 Europe Antipsychotic Drugs Market Size Outlook by Type, 2021- 2030
5.6 Europe Antipsychotic Drugs Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Antipsychotic Drugs Market, 2025
5.8 North America Antipsychotic Drugs Market Size Outlook by Type, 2021- 2030
5.9 North America Antipsychotic Drugs Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Antipsychotic Drugs Market, 2025
5.11 South America Pacific Antipsychotic Drugs Market Size Outlook by Type, 2021- 2030
5.12 South America Antipsychotic Drugs Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Antipsychotic Drugs Market, 2025
5.14 Middle East Africa Antipsychotic Drugs Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Antipsychotic Drugs Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Antipsychotic Drugs Market Size Outlook and Revenue Growth Forecasts
6.2 US Antipsychotic Drugs Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Antipsychotic Drugs Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Antipsychotic Drugs Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Antipsychotic Drugs Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Antipsychotic Drugs Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Antipsychotic Drugs Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Antipsychotic Drugs Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Antipsychotic Drugs Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Antipsychotic Drugs Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Antipsychotic Drugs Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Antipsychotic Drugs Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Antipsychotic Drugs Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Antipsychotic Drugs Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Antipsychotic Drugs Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Antipsychotic Drugs Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Antipsychotic Drugs Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Antipsychotic Drugs Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Antipsychotic Drugs Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Antipsychotic Drugs Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Antipsychotic Drugs Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Antipsychotic Drugs Industry Drivers and Opportunities
7. ANTIPSYCHOTIC DRUGS MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. ANTIPSYCHOTIC DRUGS COMPANY PROFILES
8.1 Profiles of Leading Antipsychotic Drugs Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
AbbVie Inc
Acadia Pharmaceuticals Inc
Alkermes
AstraZeneca plc
Eli Lily and Company
GlaxoSmithKline plc
H. Lundbeck A/S
Intra-Cellular Therapies Inc
Johnson & Johnson
Otsuka Pharmaceutical Co Ltd
Pfizer Inc
Sumitomo Pharma Co. Ltd
Teva Pharmaceutical Industries Ltd
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
1.1 Antipsychotic Drugs Market Overview and Key Findings, 2024
1.2 Antipsychotic Drugs Market Size and Growth Outlook, 2021- 2030
1.3 Antipsychotic Drugs Market Growth Opportunities to 2030
1.4 Key Antipsychotic Drugs Market Trends and Challenges
1.4.1 Antipsychotic Drugs Market Drivers and Trends
1.4.2 Antipsychotic Drugs Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Antipsychotic Drugs Companies
2. ANTIPSYCHOTIC DRUGS MARKET SIZE OUTLOOK TO 2030
2.1 Antipsychotic Drugs Market Size Outlook, USD Million, 2021- 2030
2.2 Antipsychotic Drugs Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. ANTIPSYCHOTIC DRUGS MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. ANTIPSYCHOTIC DRUGS MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Class Type
First Generation
-Haldo
-Navane
-Others
Second Generation
-Invega
-Latuda
-Seroquel
-Risperdal
-Zyprexa
-Geodon
-Others
Third generation
-Abilify
By Application
Schizophrenia
Bipolar disorders
Dementia
Unipolar Depression
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Antipsychotic Drugs Market, 2025
5.2 Asia Pacific Antipsychotic Drugs Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Antipsychotic Drugs Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Antipsychotic Drugs Market, 2025
5.5 Europe Antipsychotic Drugs Market Size Outlook by Type, 2021- 2030
5.6 Europe Antipsychotic Drugs Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Antipsychotic Drugs Market, 2025
5.8 North America Antipsychotic Drugs Market Size Outlook by Type, 2021- 2030
5.9 North America Antipsychotic Drugs Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Antipsychotic Drugs Market, 2025
5.11 South America Pacific Antipsychotic Drugs Market Size Outlook by Type, 2021- 2030
5.12 South America Antipsychotic Drugs Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Antipsychotic Drugs Market, 2025
5.14 Middle East Africa Antipsychotic Drugs Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Antipsychotic Drugs Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Antipsychotic Drugs Market Size Outlook and Revenue Growth Forecasts
6.2 US Antipsychotic Drugs Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Antipsychotic Drugs Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Antipsychotic Drugs Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Antipsychotic Drugs Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Antipsychotic Drugs Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Antipsychotic Drugs Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Antipsychotic Drugs Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Antipsychotic Drugs Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Antipsychotic Drugs Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Antipsychotic Drugs Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Antipsychotic Drugs Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Antipsychotic Drugs Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Antipsychotic Drugs Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Antipsychotic Drugs Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Antipsychotic Drugs Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Antipsychotic Drugs Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Antipsychotic Drugs Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Antipsychotic Drugs Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Antipsychotic Drugs Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Antipsychotic Drugs Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Antipsychotic Drugs Industry Drivers and Opportunities
7. ANTIPSYCHOTIC DRUGS MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. ANTIPSYCHOTIC DRUGS COMPANY PROFILES
8.1 Profiles of Leading Antipsychotic Drugs Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
AbbVie Inc
Acadia Pharmaceuticals Inc
Alkermes
AstraZeneca plc
Eli Lily and Company
GlaxoSmithKline plc
H. Lundbeck A/S
Intra-Cellular Therapies Inc
Johnson & Johnson
Otsuka Pharmaceutical Co Ltd
Pfizer Inc
Sumitomo Pharma Co. Ltd
Teva Pharmaceutical Industries Ltd
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
